Please use this identifier to cite or link to this item:
|Title:||High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia||Authors:||Lee, H.-Y.
|Issue Date:||Jun-2009||Citation:||Lee, H.-Y., Su, L.-H., Tsai, M.-H., Kim, S.-W., Chang, H.-H., Jung, S.-I., Park, K.-H., Perera, J., Carlos, C., Ban, H.T., Kumarasinghe, G., So, T., ChongthaLeong, A., Hsueh, P.-R., Liu, J.-W., Song, J.-H., Chiu, C.-H. (2009-06). High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrobial Agents and Chemotherapy 53 (6) : 2696-2699. ScholarBank@NUS Repository. https://doi.org/10.1128/AAC.01297-08||Abstract:||This multinational study from Asia revealed that reduced susceptibility to ciprofloxacin (MIC, 0.125 to 1 μg/ml) in nontyphoid Salmonella isolates was common in Taiwan (48.1%) and Thailand (46.2%) and in S. enterica serotype Choleraesuis (68.8%) and S. Virchow (75.0%) from all countries. Reduced susceptibility to ceftriaxone (MIC, 2 to 8 μg/ml) remained uncommon in Asia, except in Taiwan (38.0%) or in S. Typhimurium (25.0%) from all countries. Copyright © 2009, American Society for Microbiology. All Rights Reserved.||Source Title:||Antimicrobial Agents and Chemotherapy||URI:||http://scholarbank.nus.edu.sg/handle/10635/133364||ISSN:||00664804||DOI:||10.1128/AAC.01297-08|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 25, 2020
WEB OF SCIENCETM
checked on Mar 17, 2020
checked on Mar 27, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.